Voyager Therapeutics Inc (NASDAQ:VYGR)
| 7.57 Delayed Data As of 3:59pm ET |  -0.19 / -2.45%Today’s Change | 5.27 Today|||52-Week Range 14.34 | +24.10% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 2.1M | 2.0M | 5.2M | 46.1M | |
| Depreciation And Amortization | 566.0K | 579.0K | 616.0K | 676.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 22.7M | 24.6M | 33.9M | 36.2M | ||
| Research And Development | 16.6M | 16.9M | 24.8M | 27.9M | ||
| Total Operating Expenses | 23.2M | 25.2M | 34.5M | 36.9M | ||
| Non-Operating Expenses | Operating Income | -21.1M | -23.2M | -29.3M | 9.2M | |
| Other Expenses | -84.0K | -282.0K | 978.0K | -133.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -20.3M | -22.5M | -27.2M | 11.2M | |
| Net Income | -20.3M | -22.5M | -27.2M | 11.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 32.2M | 32.3M | 33.4M | 36.6M | |
| Shares To Calculate EPS Diluted | 32.2M | 32.3M | 33.4M | 37.9M | ||
| Earnings Per Share | EPS | -$0.63 | -$0.70 | -$0.81 | $0.29 | |
| EPS Diluted | -$0.63 | -$0.70 | -$0.81 | $0.29 | ||
